13F-HR filed by Cormorant Asset Management, LP
Cormorant Asset Management, LP filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 19:47:24 UTC, with 60 holding rows worth $1,489,258,905.
- Accession
- 0001583977-26-000011
- Filer
- CIK 1583977
- Filed
- 2026-11-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
13F report for Q3 2026
A holdings report, 60 entries on the cover page, a total value of $1,489,258,905 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,489,258,905 with VALUE read as dollars as filed, 13F file number 028-15949. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerChen Bihua028-15950
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| PARABILIS MEDICINES INC COM | 698955101 | Stock | 4,615,612 | $149,038,111 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 500,000 | $145,615,000 | dollars as filed | |
| RAPPORT THERAPEUTICS INC COM | 75383L102 | Stock | 2,457,521 | $82,572,706 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 1,860,000 | $75,516,000 | dollars as filed | |
| BRIDGEBIO ONCOLOGY THERAPEUT | 107924102 | COM NEW | 17,878,594 | $73,302,235 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 5,000,000 | $73,300,000 | dollars as filed | |
| BLOSSOMHILL THERAPEUTICS INC | 095130100 | COM | 3,614,034 | $67,365,594 | dollars as filed | |
| Adlai Nortye | 00704R109 | SPONSORED ADS | 3,978,229 | $63,651,664 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 500,000 | $44,025,000 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 425,000 | $42,083,500 | dollars as filed | |
| BRIGHT MINDS BIOSCIENCES INC | 10919W405 | COMMON STOCK | 800,000 | $39,856,000 | dollars as filed | |
| Electra Therapeutics, Inc. | 284825106 | Common Stock, $0.0001 par value per share | 3,365,533 | $37,862,249 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 2,855,433 | $33,408,566 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 400,000 | $33,316,000 | dollars as filed | |
| ATTOVIA THERAPEUTICS INC | 04987L102 | COM | 1,788,815 | $30,660,285 | dollars as filed | |
| FAETH THERAPEUTICS INC | 81728A207 | COM NEW | 1,028,242 | $30,579,917 | dollars as filed | |
| Latigo Biotherapeutics, Inc. | 517954103 | Common Stock, par value $0.0001 per share | 1,815,740 | $30,322,858 | dollars as filed | |
| AGOMAB THERAPEUTICS NV | 00860C102 | SPONSORED ADS | 2,465,348 | $27,365,363 | dollars as filed | |
| OPUS GENETICS INC | 67577R102 | COMMON STOCK | 5,500,000 | $26,620,000 | dollars as filed | |
| CLIMB BIO INC | 28658R106 | COMMON STOCK | 2,106,000 | $24,155,820 | dollars as filed | |
| FREENOME INC | 35661P100 | COMMON STOCK | 1,431,032 | $22,538,754 | dollars as filed | |
| MBX BIOSCIENCES INC COM | 55287L101 | Stock | 375,000 | $21,982,500 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 1,510,000 | $20,158,500 | dollars as filed | |
| ADARx Pharmaceuticals, Inc. | 00654F105 | Common Stock, par value $0.0001 per share | 962,898 | $19,200,176 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 5,750,000 | $18,802,500 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 700,000 | $17,465,000 | dollars as filed | |
| DAMORA THERAPEUTICS INC | G2646Y104 | COMM STK | 800,000 | $17,024,000 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 250,000 | $16,450,000 | dollars as filed | |
| CUE BIOPHARMA INC | 22978P205 | COM | 625,285 | $16,176,123 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 2,344,971 | $15,992,702 | dollars as filed | |
| BIOAGE LABS INC COM | 09077V100 | Stock | 2,240,605 | $15,885,889 | dollars as filed | |
| ALUMIS INC | 022307102 | COM | 2,075,000 | $15,334,250 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 1,750,000 | $15,120,000 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 450,000 | $14,274,000 | dollars as filed | |
| HELIX ACQUISITION CORP III | G4444S107 | USD CL A ORD SHS | 1,297,500 | $13,779,450 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 125,000 | $11,128,750 | dollars as filed | |
| DEFINIUM THERAPEUTICS INC | 24477V105 | COM SHS | 275,000 | $10,466,500 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 1,750,000 | $9,205,000 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 300,000 | $8,730,000 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 4,500,000 | $8,640,000 | dollars as filed | |
| INHIBRX BIOSCIENCES INC | 45720N103 | COM | 50,000 | $5,004,000 | dollars as filed | |
| KAILERA THERAPEUTICS INC | 482931102 | COMMON STOCK | 400,000 | $4,568,000 | dollars as filed | |
| JADE BIOSCIENCES INC | 008064206 | COM NEW | 300,000 | $4,215,000 | dollars as filed | |
| IBIO INC | 451033708 | CMN | 3,570,000 | $4,212,600 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 50,000 | $3,930,500 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 100,000 | $3,657,000 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 75,000 | $3,438,000 | dollars as filed | |
| ASCENDIS PHARMA A/S | K08588103 | ORD SHS *A* | 15,000 | $3,417,450 | dollars as filed | |
| Odyssey Therapeutics, Inc. | 67613T104 | COMMON STOCK | 125,000 | $2,777,500 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 100,000 | $2,432,000 | dollars as filed | |
| BOUNDLESS BIO INC | 10170A100 | COM | 940,000 | $2,359,400 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 20,000 | $2,282,800 | dollars as filed | |
| Braveheart Bio Inc | 10567X101 | COM | 70,000 | $1,414,000 | dollars as filed | |
| Research Alliance Corp Iii Ord Shs Cl A | G75226103 | Common Stock | 125,000 | $1,353,750 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 50,000 | $1,321,500 | dollars as filed | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 15,000 | $981,750 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 30,000 | $960,600 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 30,000 | $938,100 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 15,000 | $853,500 | dollars as filed | |
| QUINCE THERAPEUTICS INC COM | 22053A305 | Stock | 5,498 | $170,493 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001583977-26-000011 | this filing | 2026-11-16 |